BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Simone G, Gottdiener JS, Chinali M, Maurer MS. Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study. Eur Heart J. 2008;29:741-747. [PMID: 18204091 DOI: 10.1093/eurheartj/ehm605] [Cited by in Crossref: 159] [Cited by in F6Publishing: 144] [Article Influence: 11.4] [Reference Citation Analysis]
Number Citing Articles
1 Cioffi G, de Simone G, Cramariuc D, Mureddu GF, Gerdts E. Inappropriately high left-ventricular mass in asymptomatic mild-moderate aortic stenosis. Journal of Hypertension 2012;30:421-8. [DOI: 10.1097/hjh.0b013e32834f0b00] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
2 Buss SJ, Wolf D, Korosoglou G, Max R, Weiss CS, Fischer C, Schellberg D, Zugck C, Kuecherer HF, Lorenz H, Katus HA, Hardt SE, Hansen A. Myocardial Left Ventricular Dysfunction in Patients with Systemic Lupus Erythematosus: New Insights from Tissue Doppler and Strain Imaging. J Rheumatol 2009;37:79-86. [DOI: 10.3899/jrheum.090043] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
3 Zile MR, Desantis SM, Baicu CF, Stroud RE, Thompson SB, McClure CD, Mehurg SM, Spinale FG. Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure. Circ Heart Fail 2011;4:246-56. [PMID: 21350055 DOI: 10.1161/CIRCHEARTFAILURE.110.958199] [Cited by in Crossref: 138] [Cited by in F6Publishing: 69] [Article Influence: 12.5] [Reference Citation Analysis]
4 Camafort-babkowski M, Adeseye A, Coca A, Damasceno A, De Simone G, Dorobantu M, Jhund PS, Kario K, Komori T, Lee HY, López-jaramillo P, Ogah O, Padmanabahn S, Pascual-figal DA, Pyun WB, Renna NF, Barroso WKS, Valdez-tiburcio O, Wyss-quintana FS. The Global Ambulatory Blood Pressure Monitoring (ABPM) in Heart Failure with Preserved Ejection Fraction (HFpEF) Registry. Rationale, design and objectives. J Hum Hypertens. [DOI: 10.1038/s41371-020-00446-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tanoue MT, Kjeldsen SE, Devereux RB, Okin PM. Relationship of diastolic function to new or persistent electrocardiographic left ventricular hypertrophy. Blood Pressure 2016;25:364-72. [DOI: 10.1080/08037051.2016.1179514] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Farcaş AD, Anton FP, Goidescu CM, Gavrilă IL, Vida-Simiti LA, Stoia MA. Serum Soluble ST2 and Diastolic Dysfunction in Hypertensive Patients. Dis Markers 2017;2017:2714095. [PMID: 28566800 DOI: 10.1155/2017/2714095] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
7 Reinders I, van Ballegooijen AJ, Visser M, Elshorbagy AK, Refsum H, Henry RMA, Dekker JM, Nijpels G, Stehouwer CDA, Brouwer IA. Associations of serum n-3 and n-6 polyunsaturated fatty acids with echocardiographic measures among older adults: the Hoorn Study. Eur J Clin Nutr 2013;67:1277-83. [DOI: 10.1038/ejcn.2013.167] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
8 Dini FL, Fabiani I, Miccoli M, Galeotti GG, Pugliese NR, D'Agostino A, Scartabelli A, Conte L, Salvetti G, Santini F, Pedrinelli R. Prevalence and determinants of left ventricular diastolic dysfunction in obese subjects and the role of left ventricular global longitudinal strain and mass normalized to height. Echocardiography 2018;35:1124-31. [PMID: 29664200 DOI: 10.1111/echo.13890] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
9 Huang C, Li S. Correlation research between osteoporosis and left ventricular hypertrophy in older men. Arch Med Sci 2016;12:1220-4. [PMID: 27904511 DOI: 10.5114/aoms.2016.62910] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 de las Fuentes L, de Simone G, Arnett DK, Dávila-Román VG. Molecular determinants of the cardiometabolic phenotype. Endocr Metab Immune Disord Drug Targets 2010;10:109-23. [PMID: 20384572 DOI: 10.2174/187153010791213119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Georgiopoulos G, Aimo A, Barison A, Magkas N, Emdin M, Masci PG. Imaging predictors of incident heart failure: a systematic review and meta-analysis. J Cardiovasc Med (Hagerstown) 2021;22:378-87. [PMID: 33136816 DOI: 10.2459/JCM.0000000000001133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lavine SJ, Al Balbissi K. Adverse Cardiac Events and the Impaired Relaxation Left Ventricular Filling Pattern. Journal of the American Society of Echocardiography 2016;29:699-708. [DOI: 10.1016/j.echo.2016.02.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Dörr M, Ittermann T, Aumann N, Obst A, Reffelmann T, Nauck M, Wallaschofski H, Felix SB, Völzke H. Subclinical hyperthyroidism is not associated with progression of cardiac mass and development of left ventricular hypertrophy in middle-aged and older subjects: results from a 5-year follow-up. Clin Endocrinol (Oxf) 2010;73:821-6. [PMID: 20874773 DOI: 10.1111/j.1365-2265.2010.03882.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
14 Cox AJ, Hugenschmidt CE, Wang PT, Hsu FC, Kenchaiah S, Daniel K, Langefeld CD, Freedman BI, Herrington DM, Carr JJ. Usefulness of biventricular volume as a predictor of mortality in patients with diabetes mellitus (from the Diabetes Heart Study). Am J Cardiol. 2013;111:1152-1158. [PMID: 23351459 DOI: 10.1016/j.amjcard.2012.12.044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
15 Klein R, Ametepe ES, Yam Y, Dwivedi G, Chow BJ. Cardiac CT assessment of left ventricular mass in mid-diastasis and its prognostic value. Eur Heart J Cardiovasc Imaging 2017;18:95-102. [PMID: 26850628 DOI: 10.1093/ehjci/jev357] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
16 Santos M, Shah AM. Alterations in cardiac structure and function in hypertension. Curr Hypertens Rep 2014;16:428. [PMID: 24639061 DOI: 10.1007/s11906-014-0428-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 7.0] [Reference Citation Analysis]
17 Nichols WW, Petersen JW, Denardo SJ, Christou DD. Arterial stiffness, wave reflection amplitude and left ventricular afterload are increased in overweight individuals. ARTRES 2013;7:222. [DOI: 10.1016/j.artres.2013.08.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
18 Zhao Z, Yuan Z, Ji Y, Wu Y, Qi Y. Left ventricular hypertrophy amplifies the QT, and Tp-e intervals and the Tp-e/ QT ratio of left chest ECG. J Biomed Res 2010;24:69-72. [PMID: 23554614 DOI: 10.1016/S1674-8301(10)60011-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
19 Chen Y, Yuan J, Jiang G, Zhu J, Zou Y, Lv Q. Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling. Mol Med Rep 2017;16:4545-52. [PMID: 28849081 DOI: 10.3892/mmr.2017.7211] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
20 Akintoye E, Mahmoud K, Shokr M, Sandio A, Mallikethi-Reddy S, Sheikh M, Adegbala O, Egbe A, Briasoulis A, Afonso L. Racial/ethnic differences in the prognostic utility of left ventricular mass index for incident cardiovascular disease. Clin Cardiol 2018;41:502-9. [PMID: 29663526 DOI: 10.1002/clc.22914] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
21 Gruszczyńska K, Krzych LJ, Gołba KS, Biernat J, Roleder T, Deja MA, Ulbrych P, Malinowski M, Janusiewicz P, Woś S, Baron J. Statistical agreement of left ventricle measurements using cardiac magnetic resonance and 2D echocardiography in ischemic heart failure. Med Sci Monit 2012;18:MT19-25. [PMID: 22367134 DOI: 10.12659/msm.882507] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
22 Krysztofiak H, Młyńczak M, Małek ŁA, Folga A, Braksator W. Left ventricular mass normalization for body size in children based on an allometrically adjusted ratio is as accurate as normalization based on the centile curves method. PLoS One 2019;14:e0225287. [PMID: 31751386 DOI: 10.1371/journal.pone.0225287] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Curl CL, Danes VR, Bell JR, Raaijmakers AJA, Ip WTK, Chandramouli C, Harding TW, Porrello ER, Erickson JR, Charchar FJ, Kompa AR, Edgley AJ, Crossman DJ, Soeller C, Mellor KM, Kalman JM, Harrap SB, Delbridge LMD. Cardiomyocyte Functional Etiology in Heart Failure With Preserved Ejection Fraction Is Distinctive-A New Preclinical Model. J Am Heart Assoc 2018;7:e007451. [PMID: 29858360 DOI: 10.1161/JAHA.117.007451] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
24 Eren M, Place AT, Thomas PM, Flevaris P, Miyata T, Vaughan DE. PAI-1 is a critical regulator of FGF23 homeostasis. Sci Adv 2017;3:e1603259. [PMID: 28924605 DOI: 10.1126/sciadv.1603259] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
25 Atherton JJ. Screening for Left Ventricular Systolic Dysfunction: Is Imaging a Solution? JACC: Cardiovascular Imaging 2010;3:421-8. [DOI: 10.1016/j.jcmg.2009.11.014] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
26 Chang KF, Lin G, Huang PC, Juan YH, Wang CH, Tsai SY, Lin YC, Wu MT, Liao PA, Yang LY, Liu MH, Lin YC, Wang JJ, Ng KK, Ng SH. Left Ventricular Function and Myocardial Triglyceride Content on 3T Cardiac MR Predict Major Cardiovascular Adverse Events and Readmission in Patients Hospitalized with Acute Heart Failure. J Clin Med 2020;9:E169. [PMID: 31936313 DOI: 10.3390/jcm9010169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Norris T, Mansukoski L, Gilthorpe MS, Hamer M, Hardy R, Howe LD, Hughes AD, Li L, O'Donnell E, Ong KK, Ploubidis GB, Silverwood RJ, Viner RM, Johnson W. Distinct Body Mass Index Trajectories to Young-Adulthood Obesity and Their Different Cardiometabolic Consequences. Arterioscler Thromb Vasc Biol 2021;41:1580-93. [PMID: 33657884 DOI: 10.1161/ATVBAHA.120.315782] [Reference Citation Analysis]
28 Solomon SD, Appelbaum E, Manning WJ, Verma A, Berglund T, Lukashevich V, Cherif Papst C, Smith BA, Dahlöf B; Aliskiren in Left Ventricular Hypertrophy (ALLAY) Trial Investigators. Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy. Circulation. 2009;119:530-537. [PMID: 19153265 DOI: 10.1161/circulationaha.108.826214] [Cited by in Crossref: 226] [Cited by in F6Publishing: 74] [Article Influence: 17.4] [Reference Citation Analysis]
29 Ferro EG, Abrahams-Gessel S, Jardim TV, Wagner R, Gomez-Olive FX, Wade AN, Peters F, Tollman S, Gaziano TA. Echocardiographic and Electrocardiographic Abnormalities Among Elderly Adults With Cardiovascular Disease in Rural South Africa. Circ Cardiovasc Qual Outcomes 2021;14:e007847. [PMID: 34784231 DOI: 10.1161/CIRCOUTCOMES.121.007847] [Reference Citation Analysis]
30 Cermakova P, Muller M, Armstrong AC, Religa D, Bryan RN, Lima JAC, Launer LJ. Subclinical Cardiac Dysfunction and Brain Health in Midlife: CARDIA (Coronary Artery Risk Development in Young Adults) Brain Magnetic Resonance Imaging Substudy. J Am Heart Assoc 2017;6:e006750. [PMID: 29246962 DOI: 10.1161/JAHA.117.006750] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
31 Yola IM, Oh A, Mitchell GF, O'Connor G, Cheng S, Vasan RS, Xanthakis V. Association of lung diffusion capacity with cardiac remodeling and risk of heart failure: The Framingham heart study. PLoS One 2021;16:e0246355. [PMID: 33592021 DOI: 10.1371/journal.pone.0246355] [Reference Citation Analysis]
32 Ekundayo OJ, Dell'Italia LJ, Sanders PW, Arnett D, Aban I, Love TE, Filippatos G, Anker SD, Lloyd-Jones DM, Bakris G, Mujib M, Ahmed A. Association between hyperuricemia and incident heart failure among older adults: a propensity-matched study. Int J Cardiol 2010;142:279-87. [PMID: 19201041 DOI: 10.1016/j.ijcard.2009.01.010] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 5.1] [Reference Citation Analysis]
33 Ghannam M, Yokokawa M, Liang JJ, Cochet H, Jais P, Dabagh GS, Latchamsetty R, Jongnarangsin K, Morady F, Bogun F. Clinical significance of myocardial scar in patients with frequent premature ventricular complexes undergoing catheter ablation. Heart Rhythm 2021;18:20-6. [PMID: 32721479 DOI: 10.1016/j.hrthm.2020.07.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Stratmann B, Gawlowski T, Tschoepe D. Diabetic cardiomyopathy--to take a long story serious. Herz 2010;35:161-8. [PMID: 20467928 DOI: 10.1007/s00059-010-3336-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
35 Chien CY, Liu CC, Po HL, Yen CH, Hou CJ, Kuo JY, Hung CL, Wang SS, Yeh HI, Lam CS. The Relationship among Carotid Artery Remodeling, Cardiac Geometry, and Serum N-Terminal Pro-B-Type Natriuretic Peptide Level in Asymptomatic Asians: Sex-Differences and Longitudinal GEE Study. PLoS One 2015;10:e0131440. [PMID: 26132728 DOI: 10.1371/journal.pone.0131440] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
36 Grabner A, Amaral AP, Schramm K, Singh S, Sloan A, Yanucil C, Li J, Shehadeh LA, Hare JM, David V, Martin A, Fornoni A, Di Marco GS, Kentrup D, Reuter S, Mayer AB, Pavenstädt H, Stypmann J, Kuhn C, Hille S, Frey N, Leifheit-Nestler M, Richter B, Haffner D, Abraham R, Bange J, Sperl B, Ullrich A, Brand M, Wolf M, Faul C. Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy. Cell Metab 2015;22:1020-32. [PMID: 26437603 DOI: 10.1016/j.cmet.2015.09.002] [Cited by in Crossref: 292] [Cited by in F6Publishing: 263] [Article Influence: 41.7] [Reference Citation Analysis]
37 von Jeinsen B, Short MI, Larson MG, Xanthakis V, McManus DD, Benjamin EJ, Mitchell GF, Aragam J, Cheng S, Vasan RS. Prognostic Significance of Echocardiographic Measures of Cardiac Remodeling. J Am Soc Echocardiogr 2020;33:72-81.e6. [PMID: 31624026 DOI: 10.1016/j.echo.2019.08.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
38 Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS, Ferdinand KC, Forciea MA, Frishman WH, Jaigobin C, Kostis JB, Mancia G, Oparil S, Ortiz E, Reisin E, Rich MW, Schocken DD, Weber MA, Wesley DJ. ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 2011;123:2434-506. [DOI: 10.1161/cir.0b013e31821daaf6] [Cited by in Crossref: 219] [Cited by in F6Publishing: 101] [Article Influence: 19.9] [Reference Citation Analysis]
39 Seravalle G, Dell’oro R, Grassi G. Baroreflex activation therapy systems: current status and future prospects. Expert Review of Medical Devices 2019;16:1025-33. [DOI: 10.1080/17434440.2019.1697230] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
40 Bancks MP, Carnethon MR, Chow LS, Gidding SS, Jacobs DR Jr, Kishi S, Lima J, Lloyd-Jones D, Reis JP, Schreiner PJ, Zmora R, Allen NB. Fasting glucose and insulin resistance trajectories during young adulthood and mid-life cardiac structure and function. J Diabetes Complications 2019;33:356-62. [PMID: 30885553 DOI: 10.1016/j.jdiacomp.2019.01.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
41 Rizzi É, Castro MM, Prado CM, Silva CA, Fazan R, Rossi MA, Tanus-santos JE, Gerlach RF. Matrix Metalloproteinase Inhibition Improves Cardiac Dysfunction and Remodeling in 2-Kidney, 1-Clip Hypertension. Journal of Cardiac Failure 2010;16:599-608. [DOI: 10.1016/j.cardfail.2010.02.005] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
42 Corriere MA, Hoyle JR, Craven TE, D'agostino RB, Edwards MS, Moore PS, Hansen KJ. Changes in Left Ventricular Structure and Function following Renal Artery Revascularization. Annals of Vascular Surgery 2010;24:80-4. [DOI: 10.1016/j.avsg.2009.05.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
43 Tadic M, Cuspidi C, Calicchio F, Grassi G, Mancia G. Diagnostic algorithm for HFpEF: how much is the recent consensus applicable in clinical practice? Heart Fail Rev 2020. [PMID: 32346825 DOI: 10.1007/s10741-020-09966-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
44 van Oort S, Beulens JW, van der Heijden AAWA, Elders PJM, Stehouwer CDA, van de Luitgaarden IAT, Schrieks IC, Grobbee DE, van Ballegooijen AJ. Moderate and heavy alcohol consumption are prospectively associated with decreased left ventricular ejection fraction: The Hoorn Study. Nutr Metab Cardiovasc Dis 2020;30:132-40. [PMID: 31672450 DOI: 10.1016/j.numecd.2019.09.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
45 Chinali M, Aurigemma GP, Gerdts E, Wachtell K, Okin PM, Muthiah A, Kjeldsen SE, Julius S, de Simone G, Devereux RB. Development of systolic dysfunction unrelated to myocardial infarction in treated hypertensive patients with left ventricular hypertrophy. The LIFE Study. Exploration of Medicine. [DOI: 10.37349/emed.2022.00082] [Reference Citation Analysis]
46 Frohlich ED, González A, Díez J. Hypertensive left ventricular hypertrophy risk: beyond adaptive cardiomyocytic hypertrophy. J Hypertens 2011;29:17-26. [PMID: 21045723 DOI: 10.1097/HJH.0b013e328340d787] [Cited by in Crossref: 55] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
47 Kalogeropoulos AP, Georgiopoulou VV, deFilippi CR, Gottdiener JS, Butler J; Cardiovascular Health Study. Echocardiography, natriuretic peptides, and risk for incident heart failure in older adults: the Cardiovascular Health Study. JACC Cardiovasc Imaging 2012;5:131-40. [PMID: 22340818 DOI: 10.1016/j.jcmg.2011.11.011] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
48 Shah AB, Patel JK, Rafiei M, Morrissey RP, Kittleson MM, Kobashigawa JA. The impact of mean first-year heart rate on outcomes after heart transplantation: does it make a difference? Clin Transplant 2013;27:659-65. [PMID: 23924048 DOI: 10.1111/ctr.12188] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
49 Reffelmann T, Dörr M, Völzke H, Kors J, Ruppert J, Robinson D, Felix SB. Combination of electrocardiographic and echocardiographic information identifies individuals prone to a progressive increase in left ventricular mass over 5 years. Journal of Hypertension 2009;27:861-8. [DOI: 10.1097/hjh.0b013e328324f8e8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
50 Liu YL, Kong CY, Song P, Zhou H, Zhao XS, Tang QZ. Maslinic acid protects against pressure overload-induced cardiac hypertrophy in mice. J Pharmacol Sci 2018;138:116-22. [PMID: 30389277 DOI: 10.1016/j.jphs.2018.08.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
51 Vanelli CP, Costa MB, Colugnati FAB, Pinheiro HS, Paula EAD, Simão CCAL, Casagrande MZ, Sousa KVD, Paula RBD. Dialogue between primary and secondary health care providers in a Brazilian hypertensive population. Rev Assoc Med Bras 2018;64:799-805. [DOI: 10.1590/1806-9282.64.09.799] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
52 Bisserier M, Berthouze-Duquesnes M, Breckler M, Tortosa F, Fazal L, de Régibus A, Laurent AC, Varin A, Lucas A, Branchereau M, Marck P, Schickel JN, Deloménie C, Cazorla O, Soulas-Sprauel P, Crozatier B, Morel E, Heymes C, Lezoualc'h F. Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+/calmodulin-dependent protein kinase II signaling. Circulation 2015;131:390-400; discussion 400. [PMID: 25369805 DOI: 10.1161/CIRCULATIONAHA.114.010686] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
53 Aung N, Vargas JD, Yang C, Cabrera CP, Warren HR, Fung K, Tzanis E, Barnes MR, Rotter JI, Taylor KD, Manichaikul AW, Lima JAC, Bluemke DA, Piechnik SK, Neubauer S, Munroe PB, Petersen SE. Genome-Wide Analysis of Left Ventricular Image-Derived Phenotypes Identifies Fourteen Loci Associated With Cardiac Morphogenesis and Heart Failure Development. Circulation 2019;140:1318-30. [PMID: 31554410 DOI: 10.1161/CIRCULATIONAHA.119.041161] [Cited by in Crossref: 48] [Cited by in F6Publishing: 24] [Article Influence: 16.0] [Reference Citation Analysis]
54 Di Palo KE, Barone NJ. Hypertension and Heart Failure. Heart Failure Clinics 2020;16:99-106. [DOI: 10.1016/j.hfc.2019.09.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
55 Laitinen TT, Puolakka E, Ruohonen S, Magnussen CG, Smith KJ, Viikari JSA, Heinonen OJ, Kartiosuo N, Hutri-Kähönen N, Kähönen M, Jokinen E, Laitinen TP, Tossavainen P, Pulkki-Råback L, Elovainio M, Raitakari OT, Pahkala K, Juonala M. Association of Socioeconomic Status in Childhood With Left Ventricular Structure and Diastolic Function in Adulthood: The Cardiovascular Risk in Young Finns Study. JAMA Pediatr 2017;171:781-7. [PMID: 28655058 DOI: 10.1001/jamapediatrics.2017.1085] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
56 Slivnick J, Lampert BC. Hypertension and Heart Failure. Heart Fail Clin 2019;15:531-41. [PMID: 31472888 DOI: 10.1016/j.hfc.2019.06.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
57 Valensi P, Henry P, Boccara F, Cosson E, Prevost G, Emmerich J, Ernande L, Marcadet D, Mousseaux E, Rouzet F, Sultan A, Ferrières J, Vergès B, Van Belle E. Risk stratification and screening for coronary artery disease in asymptomatic patients with diabetes mellitus: Position paper of the French Society of Cardiology and the French-speaking Society of Diabetology. Arch Cardiovasc Dis 2021;114:150-72. [PMID: 33309203 DOI: 10.1016/j.acvd.2020.07.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Maisel AS. Cardiovascular and renal surrogate markers in the clinical management of hypertension. Cardiovasc Drugs Ther 2009;23:317-26. [PMID: 19572190 DOI: 10.1007/s10557-009-6177-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
59 Davies C, Zerebiec K, Rożanowska A, Czestkowska E, Długosz D, Chyrchel B, Surdacki A. Is left ventricular hypertrophy a friend or foe of patients with aortic stenosis? Postepy Kardiol Interwencyjnej 2018;14:328-37. [PMID: 30603022 DOI: 10.5114/aic.2018.78734] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
60 Rashid H, Mende C. The Role of Direct Renin Inhibition in Clinical Practice: Focus on Combination Therapy. American Journal Cardiovascular Drugs 2011;11:303-15. [DOI: 10.2165/11594140-000000000-00000] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
61 Haring R, Völzke H, Vasan RS, Felix SB, Nauck M, Dörr M, Wallaschofski H. Sex-specific associations of serum prolactin concentrations with cardiac remodeling: Longitudinal results from the Study of Health Pomerania (SHIP). Atherosclerosis 2012;221:570-6. [DOI: 10.1016/j.atherosclerosis.2012.01.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
62 van den Hurk K, Alssema M, Kamp O, Henry RM, Stehouwer CD, Diamant M, Boomsma F, Heine RJ, Nijpels G, Paulus WJ, Dekker JM. Slightly elevated B-type natriuretic peptide levels in a non-heart failure range indicate a worse left ventricular diastolic function in individuals with, as compared with individuals without, type 2 diabetes: the Hoorn Study. European Journal of Heart Failure 2010;12:958-65. [DOI: 10.1093/eurjhf/hfq119] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
63 Alshawabkeh LI, Yee LM, Gardin JM, Gottdiener JS, Odden MC, Bartz TM, Arnold AM, Mukamal KJ, Wallace RB. Years of able life in older persons--the role of cardiovascular imaging and biomarkers: the Cardiovascular Health Study. J Am Heart Assoc 2015;4:e001745. [PMID: 25907126 DOI: 10.1161/JAHA.114.001745] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
64 Dénes M, Kiss I, Lengyel M. Assessment of diastolic dysfunction in elderly hypertensive patients using integrated Doppler echocardiography. Blood Pressure 2009;18:135-41. [DOI: 10.1080/08037050903013899] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
65 Mewton N, Opdahl A, Choi EY, Almeida AL, Kawel N, Wu CO, Burke GL, Liu S, Liu K, Bluemke DA, Lima JA. Left ventricular global function index by magnetic resonance imaging--a novel marker for assessment of cardiac performance for the prediction of cardiovascular events: the multi-ethnic study of atherosclerosis. Hypertension 2013;61:770-8. [PMID: 23424238 DOI: 10.1161/HYPERTENSIONAHA.111.198028] [Cited by in F6Publishing: 28] [Reference Citation Analysis]
66 Ma ZG, Dai J, Wei WY, Zhang WB, Xu SC, Liao HH, Yang Z, Tang QZ. Asiatic Acid Protects against Cardiac Hypertrophy through Activating AMPKα Signalling Pathway. Int J Biol Sci 2016;12:861-71. [PMID: 27313499 DOI: 10.7150/ijbs.14213] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 6.8] [Reference Citation Analysis]
67 Edelmann F. [Epidemiology and prognosis of heart failure]. Herz 2015;40:176-84. [PMID: 25822419 DOI: 10.1007/s00059-015-4215-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
68 Krepp JM, Lin F, Min JK, Devereux RB, Okin PM. Relationship of electrocardiographic left ventricular hypertrophy to the presence of diastolic dysfunction. Ann Noninvasive Electrocardiol 2014;19:552-60. [PMID: 24750238 DOI: 10.1111/anec.12166] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
69 Xing F, Chen J, Zhao B, Jiang J, Tang A, Chen Y. Real role of β-blockers in regression of left ventricular mass in hypertension patients: Bayesian network meta-analysis. Medicine (Baltimore) 2017;96:e6290. [PMID: 28272254 DOI: 10.1097/MD.0000000000006290] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.6] [Reference Citation Analysis]
70 Chen L, Huang J, Ji Y, Zhang X, Wang P, Deng K, Jiang X, Ma G, Li H. Tripartite motif 32 prevents pathological cardiac hypertrophy. Clin Sci (Lond) 2016;130:813-28. [PMID: 26884348 DOI: 10.1042/CS20150619] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
71 Coller J, Campbell D, Krum H, Prior D. Early Identification of Asymptomatic Subjects at Increased Risk of Heart Failure and Cardiovascular Events: Progress and Future Directions. Heart, Lung and Circulation 2013;22:171-8. [DOI: 10.1016/j.hlc.2012.09.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
72 Barrabés JA, Figueras J, Cortadellas J, Lidón R, Ibars S. Usefulness of Electrocardiographic and Echocardiographic Left Ventricular Hypertrophy to Predict Adverse Events in Patients With a First Non–ST-Elevation Acute Myocardial Infarction. The American Journal of Cardiology 2009;103:455-60. [DOI: 10.1016/j.amjcard.2008.10.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
73 Gerdts E, Rossebø AB, Pedersen TR, Cioffi G, Lønnebakken MT, Cramariuc D, Rogge BP, Devereux RB. Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis. Circ Cardiovasc Imaging 2015;8:e003644; discussion e003644. [PMID: 26489804 DOI: 10.1161/CIRCIMAGING.115.003644] [Cited by in Crossref: 64] [Cited by in F6Publishing: 27] [Article Influence: 10.7] [Reference Citation Analysis]
74 Eng J, McClelland RL, Gomes AS, Hundley WG, Cheng S, Wu CO, Carr JJ, Shea S, Bluemke DA, Lima JA. Adverse Left Ventricular Remodeling and Age Assessed with Cardiac MR Imaging: The Multi-Ethnic Study of Atherosclerosis. Radiology 2016;278:714-22. [PMID: 26485617 DOI: 10.1148/radiol.2015150982] [Cited by in Crossref: 54] [Cited by in F6Publishing: 39] [Article Influence: 7.7] [Reference Citation Analysis]
75 Losi M, Izzo R, De Marco M, Canciello G, Rapacciuolo A, Trimarco V, Stabile E, Rozza F, Esposito G, De Luca N, de Simone G, Trimarco B. Cardiovascular ultrasound exploration contributes to predict incident atrial fibrillation in arterial hypertension: The Campania Salute Network. International Journal of Cardiology 2015;199:290-5. [DOI: 10.1016/j.ijcard.2015.07.019] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
76 Kishi S, Armstrong AC, Gidding SS, Jacobs DR Jr, Sidney S, Lewis CE, Schreiner PJ, Liu K, Lima JA. Relation of left ventricular mass at age 23 to 35 years to global left ventricular systolic function 20 years later (from the Coronary Artery Risk Development in Young Adults study). Am J Cardiol 2014;113:377-83. [PMID: 24176073 DOI: 10.1016/j.amjcard.2013.08.052] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
77 Atherton JJ. Stage B heart failure: rationale for screening. Heart Fail Clin 2012;8:273-83. [PMID: 22405666 DOI: 10.1016/j.hfc.2011.11.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
78 Lai CL, Chien KL, Hsu HC, Su TC, Chen MF, Lee YT. Left ventricular mass and risk of cardiovascular events and all-cause death among ethnic Chinese--the Chin-Shan Community Cardiovascular Cohort study. Int J Cardiol. 2011;149:347-352. [PMID: 20202708 DOI: 10.1016/j.ijcard.2010.02.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
79 Sahiti F, Morbach C, Cejka V, Albert J, Eichner FA, Gelbrich G, Heuschmann PU, Störk S. Left Ventricular Remodeling and Myocardial Work: Results From the Population-Based STAAB Cohort Study. Front Cardiovasc Med 2021;8:669335. [PMID: 34179134 DOI: 10.3389/fcvm.2021.669335] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
80 Reffelmann T, Dörr M, Völzke H, Friedrich N, Krebs A, Ittermann T, Felix SB. Urinary albumin excretion, even within the normal range, predicts an increase in left ventricular mass over the following 5 years. Kidney International 2010;77:1115-22. [DOI: 10.1038/ki.2010.8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
81 Chyrchel B, Bolt K, Długosz D, Urbańska A, Nowak-Kępczyk M, Bałata J, Rożanowska A, Czestkowska E, Kruszelnicka O, Surdacki A. Better Myocardial Function in Aortic Stenosis with Low Left Ventricular Mass: A Mechanism of Protection against Heart Failure Regardless of Stenosis Severity? J Clin Med 2019;8:E1836. [PMID: 31683977 DOI: 10.3390/jcm8111836] [Reference Citation Analysis]
82 Juszczyk A, Jankowska K, Zawiślak B, Surdacki A, Chyrchel B. Depressed Cardiac Mechanical Energetic Efficiency: A Contributor to Cardiovascular Risk in Common Metabolic Diseases-From Mechanisms to Clinical Applications. J Clin Med 2020;9:E2681. [PMID: 32824903 DOI: 10.3390/jcm9092681] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
83 Lin FY, Nicolo D, Devereux RB, Labounty TM, Dunning A, Gomez M, Koduru S, Choi JH, Weinsaft JW, Simprini LA, Callister TQ, Shaw LJ, Berman DS, Min JK. Nonobstructive coronary artery disease as detected by 64-detector row cardiac computed tomographic angiography is associated with increased left ventricular mass. J Cardiovasc Comput Tomogr 2011;5:158-64. [PMID: 21376693 DOI: 10.1016/j.jcct.2011.01.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
84 Chirinos JA, Sardana M, Oldland G, Ansari B, Lee J, Hussain A, Mustafa A, Akers SR, Wei W, Lakatta EG, Fedorova OV. Association of arginine vasopressin with low atrial natriuretic peptide levels, left ventricular remodelling, and outcomes in adults with and without heart failure. ESC Heart Fail 2018;5:911-9. [PMID: 29969536 DOI: 10.1002/ehf2.12319] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
85 Lyngbakken MN, Kvisvik B, Aagaard EN, Berge T, Pervez MO, Brynildsen J, Tveit A, Steine K, Røsjø H, Omland T. B-Type Natriuretic Peptide Is Associated with Indices of Left Ventricular Dysfunction in Healthy Subjects from the General Population: The Akershus Cardiac Examination 1950 Study. Clin Chem 2021;67:204-15. [PMID: 33279958 DOI: 10.1093/clinchem/hvaa257] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
86 Muiesan ML, Salvetti M, Paini A, Agabiti-rosei C, Monteduro C, Galbassini G, Belotti E, Aggiusti C, Rizzoni D, Castellano M, Agabiti-rosei E. Inappropriate Left Ventricular Mass in Patients With Primary Aldosteronism. Hypertension 2008;52:529-34. [DOI: 10.1161/hypertensionaha.108.114140] [Cited by in Crossref: 78] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
87 Metra M, Zacà V, Parati G, Agostoni P, Bonadies M, Ciccone M, Cas AD, Iacoviello M, Lagioia R, Lombardi C, Maio R, Magrì D, Musca G, Padeletti M, Perticone F, Pezzali N, Piepoli M, Sciacqua A, Zanolla L, Nodari S, Filardi PP, Dei Cas L. Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure. Journal of Cardiovascular Medicine 2011;12:76-84. [DOI: 10.2459/jcm.0b013e32834058d1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
88 Jordan J, Toplak H, Grassi G, Yumuk V, Kotsis V, Engeli S, Cuspidi C, Nilsson PM, Finer N, Doehner W. Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and heart failure. J Hypertens 2016;34:1678-88. [PMID: 27488547 DOI: 10.1097/HJH.0000000000001013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
89 Vasan RS, Urbina EM, Jin L, Xanthakis V. Prognostic Significance of Echocardiographic Measures of Cardiac Remodeling in the Community. Curr Cardiol Rep 2021;23:86. [PMID: 34081212 DOI: 10.1007/s11886-021-01512-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Velagaleti RS, Gona P, Pencina MJ, Aragam J, Wang TJ, Levy D, D’Agostino RB, Lee DS, Kannel WB, Benjamin EJ. Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction. Am J Cardiol. 2014;113:117-122. [PMID: 24210333 DOI: 10.1016/j.amjcard.2013.09.028] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 7.8] [Reference Citation Analysis]
91 Ernande L, Bergerot C, Rietzschel ER, De Buyzere ML, Thibault H, Pignonblanc PG, Croisille P, Ovize M, Groisne L, Moulin P, Gillebert TC, Derumeaux G. Diastolic dysfunction in patients with type 2 diabetes mellitus: is it really the first marker of diabetic cardiomyopathy? J Am Soc Echocardiogr. 2011;24:1268-1275.el. [PMID: 21907542 DOI: 10.1016/j.echo.2011.07.017] [Cited by in Crossref: 129] [Cited by in F6Publishing: 128] [Article Influence: 11.7] [Reference Citation Analysis]
92 Nolly MB, Pinilla AO, Ennis IL, Cingolani HE, Morgan PE. Cardiac hypertrophy reduction in SHR by specific silencing of myocardial Na + /H + exchanger. Journal of Applied Physiology 2015;118:1154-60. [DOI: 10.1152/japplphysiol.00996.2014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
93 Oliveros E, Marinescu K, Suboc T, Williams KA. Hypertension Management for the Prevention of Heart Failure: Best Strategies. Curr Cardiovasc Risk Rep 2018;12. [DOI: 10.1007/s12170-018-0573-x] [Reference Citation Analysis]
94 Mureddu GF, Cioffi G, Stefenelli C, Boccanelli A, de Simone G. Compensatory or inappropriate left ventricular mass in different models of left ventricular pressure overload: comparison between patients with aortic stenosis and arterial hypertension. Journal of Hypertension 2009;27:642-9. [DOI: 10.1097/hjh.0b013e32831cec98] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
95 Hong KU, Moore JB 4th. Recent advances in cardiac myocyte biology and function. Circ Res 2013;113:e121-4. [PMID: 24311621 DOI: 10.1161/CIRCRESAHA.113.302990] [Reference Citation Analysis]
96 Hsieh YP, Huang CH, Lee CY, Chen HL, Lin CY, Chang CC. Hepcidin-25 negatively predicts left ventricular mass index in chronic kidney disease patients. World J Nephrol 2013; 2(2): 38-43 [PMID: 24175264 DOI: 10.5527/wjn.v2.i2.38] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
97 Alter P, Rupp H, Adams P, Stoll F, Figiel JH, Klose KJ, Rominger MB, Maisch B. Occurrence of late gadolinium enhancement is associated with increased left ventricular wall stress and mass in patients with non-ischaemic dilated cardiomyopathy. European Journal of Heart Failure 2011;13:937-44. [DOI: 10.1093/eurjhf/hfr082] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 4.9] [Reference Citation Analysis]
98 Rojek A, Cielecka-Prynda M, Przewlocka-Kosmala M, Laczmanski L, Mysiak A, Kosmala W. Impact of the PPARGC1A Gly482Ser polymorphism on left ventricular structural and functional abnormalities in patients with hypertension. J Hum Hypertens 2014;28:557-63. [PMID: 24718382 DOI: 10.1038/jhh.2014.26] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
99 Heiskanen JS, Hernesniemi JA, Ruohonen S, Hutri-Kähönen N, Kähönen M, Jokinen E, Tossavainen P, Kallio M, Laitinen T, Lehtimäki T, Viikari J, Juonala M, Nevalainen J, Raitakari OT. Influence of early-life body mass index and systolic blood pressure on left ventricle in adulthood - the Cardiovascular Risk in Young Finns Study. Ann Med 2021;53:160-8. [PMID: 33238748 DOI: 10.1080/07853890.2020.1849785] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
100 Murakami H, Sasaki H, Sasaki S, Hata S, Sugimoto Y, Yakabe D, Hirokami M. Prognosis of medically treated patients at least 80 years old with severe sclerotic aortic stenosis. Journal of Cardiology 2015;65:330-6. [DOI: 10.1016/j.jjcc.2014.06.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
101 Maeder MT, Kaye DM. Heart Failure With Normal Left Ventricular Ejection Fraction. Journal of the American College of Cardiology 2009;53:905-18. [DOI: 10.1016/j.jacc.2008.12.007] [Cited by in Crossref: 181] [Cited by in F6Publishing: 150] [Article Influence: 13.9] [Reference Citation Analysis]
102 Brea MS, Díaz RG, Escudero DS, Zavala MR, Portiansky EL, Villa-abrille MC, Caldiz CI, Pérez NG, Morgan PE. Silencing of epidermal growth factor receptor reduces Na+/H+ exchanger 1 activity and hypertensive cardiac hypertrophy. Biochemical Pharmacology 2019;170:113667. [DOI: 10.1016/j.bcp.2019.113667] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
103 Barrick CJ, Dong A, Waikel R, Corn D, Yang F, Threadgill DW, Smyth SS. Parent-of-origin effects on cardiac response to pressure overload in mice. Am J Physiol Heart Circ Physiol 2009;297:H1003-9. [PMID: 19561308 DOI: 10.1152/ajpheart.00896.2008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
104 D'Andrea A, Ilardi F, D'Ascenzi F, Bandera F, Benfari G, Esposito R, Malagoli A, Mandoli GE, Santoro C, Russo V, D'Alto M, Cameli M; Working Group of Echocardiography of the Italian Society of Cardiology (SIC). Impaired myocardial work efficiency in heart failure with preserved ejection fraction. Eur Heart J Cardiovasc Imaging 2021;22:1312-20. [PMID: 34410362 DOI: 10.1093/ehjci/jeab153] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Kochetkov AI, Borisova EV, Ostroumova OD, Lopukhina MV, Piksina GV. Effect of the Single-Pill Amlodipine/Valsartan Combination on Hypertrophy and Myocardial Deformation Characteristics in Middle-Aged Patients with Essential Arterial Hypertension. Racionalʹnaâ farmakoterapiâ v kardiologii 2019;15:305-14. [DOI: 10.20996/1819-6446-2019-15-3-305-314] [Reference Citation Analysis]
106 Patel RB, Freed BH, Beussink-Nelson L, Allen NB, Konety SH, Post WS, Yeboah J, Kitzman DW, Bertoni AG, Shah SJ. Associations of Cardiac Mechanics With Exercise Capacity: The Multi-Ethnic Study of Atherosclerosis. J Am Coll Cardiol 2021;78:245-57. [PMID: 33992746 DOI: 10.1016/j.jacc.2021.04.082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Di Mattia RA, Mariángelo JI, Blanco PG, Jaquenod De Giusti C, Portiansky EL, Mundiña-weilenmann C, Aiello EA, Orlowski A. The activation of the G protein-coupled estrogen receptor (GPER) prevents and regresses cardiac hypertrophy. Life Sciences 2020;242:117211. [DOI: 10.1016/j.lfs.2019.117211] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
108 Lee SW, Min HK, Chae DW, Oh KH, Ahn C, Chung W, Lee J, Kim YS, Sung SA; Representing the KNOW-CKD Study Group. Indexation of left ventricular mass to predict adverse clinical outcomes in pre-dialysis patients with chronic kidney disease: KoreaN cohort study of the outcome in patients with chronic kidney disease. PLoS One 2020;15:e0233310. [PMID: 32428014 DOI: 10.1371/journal.pone.0233310] [Reference Citation Analysis]
109 Salvetti G, Pucci A, Fierabracci P, Ceccarini G, Palagi C, Delle Donne MG, Di Bello V, Piaggi P, Vitti P, Salvetti A, Pinchera A, Santini F. Prevalence of Left Ventricular Hypertrophy and Determinants of Left Ventricular Mass in Obese Women: . High Blood Pressure & Cardiovascular Prevention 2012;19:33-9. [DOI: 10.2165/11593700-000000000-00000] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
110 Raimondi F, Chinali M, Girfoglio D, Benincasa M, Pasquini L, Emma F, de Simone G, Chiara Matteucci M. Inappropriate left ventricular mass in children and young adults with chronic renal insufficiency. Pediatr Nephrol 2009;24:2015-22. [PMID: 19444482 DOI: 10.1007/s00467-009-1201-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
111 Chen L, Huang J, Ji Y, Mei F, Wang P, Deng K, Jiang X, Ma G, Li H. Tripartite Motif 8 Contributes to Pathological Cardiac Hypertrophy Through Enhancing Transforming Growth Factor β–Activated Kinase 1–Dependent Signaling Pathways. Hypertension 2017;69:249-58. [DOI: 10.1161/hypertensionaha.116.07741] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 4.6] [Reference Citation Analysis]
112 Alter P, Rupp H, Maisch B. Assessment and relevance of ventricular wall stress in heart failure. Eur Heart J 2008;29:2316. [PMID: 18621773 DOI: 10.1093/eurheartj/ehn330] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
113 Sinha A, Rivera AS, Doyle MF, Sitlani C, Fohner A, Huber SA, Olson NC, Lima JA, Delaney JA, Feinstein MJ, Shah SJ, Tracy RP, Psaty BM. Association of immune cell subsets with cardiac mechanics in the Multi-Ethnic Study of Atherosclerosis. JCI Insight 2021;6:149193. [PMID: 34236048 DOI: 10.1172/jci.insight.149193] [Reference Citation Analysis]
114 Mutlak M, Schlesinger-Laufer M, Haas T, Shofti R, Ballan N, Lewis YE, Zuler M, Zohar Y, Caspi LH, Kehat I. Extracellular signal-regulated kinase (ERK) activation preserves cardiac function in pressure overload induced hypertrophy. Int J Cardiol 2018;270:204-13. [PMID: 29857938 DOI: 10.1016/j.ijcard.2018.05.068] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
115 Chyrchel B, Długosz D, Bolt K, Kruszelnicka O, Dziewierz A, Świerszcz J, Wieczorek-Surdacka E, Hryniewiecki T, Surdacki A. Association of Inadequately Low Left Ventricular Mass with Enhanced Myocardial Contractility in Severe Degenerative Aortic Stenosis. J Clin Med 2018;7:E464. [PMID: 30469477 DOI: 10.3390/jcm7120464] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
116 Lawler PR, Hiremath P, Cheng S. Cardiac target organ damage in hypertension: insights from epidemiology. Curr Hypertens Rep 2014;16:446. [PMID: 24801135 DOI: 10.1007/s11906-014-0446-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
117 Mahfoud F, Ukena C, Pöss J, Bramlage P, Volpe M, Thoenes M, Schmieder R, Böhm M. Microalbuminuria independently correlates to cardiovascular comorbidity burden in patients with hypertension. Clin Res Cardiol 2012;101:761-6. [PMID: 22485016 DOI: 10.1007/s00392-012-0459-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
118 Weng LQ, Zhang WB, Ye Y, Yin PP, Yuan J, Wang XX, Kang L, Jiang SS, You JY, Wu J, Gong H, Ge JB, Zou YZ. Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice. Acta Pharmacol Sin 2014;35:1005-14. [PMID: 24998254 DOI: 10.1038/aps.2014.45] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
119 Przewlocka-Kosmala M, Marwick TH, Yang H, Wright L, Negishi K, Kosmala W. Association of Reduced Apical Untwisting With Incident HF in Asymptomatic Patients With HF Risk Factors. JACC Cardiovasc Imaging 2020;13:187-94. [PMID: 31103574 DOI: 10.1016/j.jcmg.2019.01.035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
120 Hamo CE, Butler J. How to Best Identify Elderly Individuals Who May Develop Heart Failure. Curr Cardiovasc Risk Rep 2016;10. [DOI: 10.1007/s12170-016-0500-y] [Reference Citation Analysis]
121 Teupe C, Rosak C. Diabetic cardiomyopathy and diastolic heart failure -- difficulties with relaxation. Diabetes Res Clin Pract 2012;97:185-94. [PMID: 22502812 DOI: 10.1016/j.diabres.2012.03.008] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
122 Li X, Lin Y, Wang S, Zhou S, Ju J, Wang X, Chen Y, Xia M. Extracellular Superoxide Dismutase Is Associated With Left Ventricular Geometry and Heart Failure in Patients With Cardiovascular Disease. J Am Heart Assoc 2020;9:e016862. [PMID: 32750295 DOI: 10.1161/JAHA.120.016862] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
123 Cioffi G, Faggiano P, Lucci D, Di Lenarda A, Mureddu GF, Tarantini L, Verdecchia P, Comaschi M, Giorda CB, Velussi M, Chinali M, Latini R, Masson S, De Simone G. Inappropriately high left ventricular mass in patients with type 2 diabetes mellitus and no overt cardiac disease. The DYDA study. Journal of Hypertension 2011;29:1994-2003. [DOI: 10.1097/hjh.0b013e32834acc6d] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
124 Yalin SF, Trabulus S, Seyahi N, Cengiz M, Cicik ME, Altiparmak MR. Ambulatory blood pressure monitoring in living kidney donors: What changes in 10 years? Clin Transplant 2018;32:e13224. [PMID: 29457269 DOI: 10.1111/ctr.13224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
125 Cuspidi C, Negri F, Giudici V, Sala C, Mancia G. Impaired midwall mechanics and biventricular hypertrophy in essential hypertension. Blood Pressure 2010;19:234-9. [DOI: 10.3109/08037051003606413] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
126 Di Palo KE, Barone NJ. Hypertension and Heart Failure. Cardiology Clinics 2022;40:237-44. [DOI: 10.1016/j.ccl.2021.12.011] [Reference Citation Analysis]
127 Lee YS, Choi JW, Oh JE, Yun CO, Kim SW. Human relaxin gene expression delivered by bioreducible dendrimer polymer for post-infarct cardiac remodeling in rats. Biomaterials 2016;97:164-75. [PMID: 27174688 DOI: 10.1016/j.biomaterials.2016.04.025] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
128 Pieske B, Wachter R. Impact of diabetes and hypertension on the heart. Current Opinion in Cardiology 2008;23:340-9. [DOI: 10.1097/hco.0b013e3283031ab3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
129 Gjesdal O, Bluemke DA, Lima JA. Cardiac remodeling at the population level—risk factors, screening, and outcomes. Nat Rev Cardiol 2011;8:673-85. [DOI: 10.1038/nrcardio.2011.154] [Cited by in Crossref: 104] [Cited by in F6Publishing: 101] [Article Influence: 9.5] [Reference Citation Analysis]
130 Masson S, Latini R, Mureddu GF, Agabiti N, Miceli M, Cesaroni G, Forastiere F, Wienhues-thelen U, Block D, Zaugg C, Vago T, Boccanelli A; on behalf of the investigators of the PREDICTOR study. High-sensitivity cardiac troponin T for detection of subtle abnormalities of cardiac phenotype in a general population of elderly individuals. J Intern Med 2013;273:306-17. [DOI: 10.1111/joim.12023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
131 Chew NWS, Ngiam JN, Tan BY, Sia CH, Ruan W, Sim HW, Kong WKF, Tay ELW, Yeo TC, Poh KK. Inadequately low left ventricular mass in patients with significant aortic stenosis predicts favourable prognostic outcomes. Int J Cardiovasc Imaging 2021;37:1611-9. [PMID: 33454894 DOI: 10.1007/s10554-020-02146-3] [Reference Citation Analysis]
132 Kosmala W, Jellis CL, Marwick TH. Exercise Limitation Associated With Asymptomatic Left Ventricular Impairment. Journal of the American College of Cardiology 2015;65:257-66. [DOI: 10.1016/j.jacc.2014.10.044] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 5.6] [Reference Citation Analysis]
133 Choi EY, Bahrami H, Wu CO, Greenland P, Cushman M, Daniels LB, Almeida AL, Yoneyama K, Opdahl A, Jain A, Criqui MH, Siscovick D, Darwin C, Maisel A, Bluemke DA, Lima JA. N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of Atherosclerosis. Circ Heart Fail 2012;5:727-34. [PMID: 23032197 DOI: 10.1161/CIRCHEARTFAILURE.112.968701] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 5.8] [Reference Citation Analysis]
134 Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS, Ferdinand KC, Ann Forciea M, Frishman WH, Jaigobin C. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Soc Hypertens. 2011;5:259-352. [PMID: 21771565 DOI: 10.1016/j.jash.2011.06.001] [Cited by in Crossref: 83] [Cited by in F6Publishing: 66] [Article Influence: 7.5] [Reference Citation Analysis]
135 Asghar O, Al-Sunni A, Khavandi K, Khavandi A, Withers S, Greenstein A, Heagerty AM, Malik RA. Diabetic cardiomyopathy. Clin Sci (Lond). 2009;116:741-760. [PMID: 19364331 DOI: 10.1042/cs20080500] [Cited by in Crossref: 111] [Cited by in F6Publishing: 59] [Article Influence: 8.5] [Reference Citation Analysis]
136 Anstey DE, Tanner RM, Booth JN 3rd, Bress AP, Diaz KM, Sims M, Ogedegbe G, Muntner P, Abdalla M. Inappropriate Left Ventricular Mass and Cardiovascular Disease Events and Mortality in Blacks: The Jackson Heart Study. J Am Heart Assoc 2019;8:e011897. [PMID: 31407619 DOI: 10.1161/JAHA.118.011897] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
137 Amigoni M, Giannattasio C, Fraschini D, Galbiati M, Capra ACM, Madotto F, Cesana F, Jankovic M, Masera G, Mancia G. Low anthracyclines doses-induced cardiotoxicity in acute lymphoblastic leukemia long-term female survivors. Pediatr Blood Cancer 2010;55:1343-7. [DOI: 10.1002/pbc.22637] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
138 Seko Y, Kato T, Yamaji Y, Haruna Y, Nakane E, Haruna T, Inoko M. Discrepancy between left ventricular hypertrophy by echocardiography and electrocardiographic hypertrophy: clinical characteristics and outcomes. Open Heart 2021;8:e001765. [PMID: 34556560 DOI: 10.1136/openhrt-2021-001765] [Reference Citation Analysis]
139 Reffelmann T, Dörr M, Ittermann T, Schwahn C, Völzke H, Ruppert J, Robinson D, Felix SB. Low serum magnesium concentrations predict increase in left ventricular mass over 5 years independently of common cardiovascular risk factors. Atherosclerosis 2010;213:563-9. [PMID: 20864108 DOI: 10.1016/j.atherosclerosis.2010.08.073] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
140 Lambers Heerspink HJ, Perkovic V, de Zeeuw D. Renal and cardio-protective effects of direct renin inhibition: a systematic literature review. J Hypertens 2009;27:2321-31. [PMID: 19727007 DOI: 10.1097/HJH.0b013e3283310f92] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
141 El-Armouche A, Ouchi N, Tanaka K, Doros G, Wittköpper K, Schulze T, Eschenhagen T, Walsh K, Sam F. Follistatin-like 1 in chronic systolic heart failure: a marker of left ventricular remodeling. Circ Heart Fail 2011;4:621-7. [PMID: 21622850 DOI: 10.1161/CIRCHEARTFAILURE.110.960625] [Cited by in Crossref: 45] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
142 Roh J, Rhee J, Chaudhari V, Rosenzweig A. The Role of Exercise in Cardiac Aging: From Physiology to Molecular Mechanisms. Circ Res 2016;118:279-95. [PMID: 26838314 DOI: 10.1161/CIRCRESAHA.115.305250] [Cited by in Crossref: 59] [Cited by in F6Publishing: 37] [Article Influence: 9.8] [Reference Citation Analysis]
143 van Berlo JH, Maillet M, Molkentin JD. Signaling effectors underlying pathologic growth and remodeling of the heart. J Clin Invest 2013;123:37-45. [PMID: 23281408 DOI: 10.1172/JCI62839] [Cited by in Crossref: 300] [Cited by in F6Publishing: 179] [Article Influence: 33.3] [Reference Citation Analysis]
144 Laitinen TT, Ruohonen S, Juonala M, Magnussen CG, Mikkilä V, Mikola H, Hutri-kähönen N, Laitinen T, Tossavainen P, Jokinen E, Niinikoski H, Jula A, Viikari JS, Rönnemaa T, Raitakari OT, Pahkala K. Ideal cardiovascular health in childhood—Longitudinal associations with cardiac structure and function: The Special Turku Coronary Risk Factor Intervention Project (STRIP) and the Cardiovascular Risk in Young Finns Study (YFS). International Journal of Cardiology 2017;230:304-9. [DOI: 10.1016/j.ijcard.2016.12.117] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
145 Altmann U, Böger CA, Farkas S, Mack M, Luchner A, Hamer OW, Zeman F, Debl K, Fellner C, Jungbauer C, Banas B, Buchner S. Effects of Reduced Kidney Function Because of Living Kidney Donation on Left Ventricular Mass. Hypertension 2017;69:297-303. [DOI: 10.1161/hypertensionaha.116.08175] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 2.6] [Reference Citation Analysis]
146 Jones PM, George AM. The ABC transporter structure and mechanism: perspectives on recent research. Cell Mol Life Sci. 2004;61:682-699. [PMID: 15052411 DOI: 10.1007/s00018-003-3336-9] [Cited by in Crossref: 339] [Cited by in F6Publishing: 312] [Article Influence: 18.8] [Reference Citation Analysis]
147 de Simone G, Devereux RB, Roman MJ, Chinali M, Barac A, Panza JA, Lee ET, Galloway JM, Howard BV. Does cardiovascular phenotype explain the association between diabetes and incident heart failure? The Strong Heart Study. Nutr Metab Cardiovasc Dis 2013;23:285-91. [PMID: 21940153 DOI: 10.1016/j.numecd.2011.06.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
148 Mehta H, Armstrong A, Swett K, Shah SJ, Allison MA, Hurwitz B, Bangdiwala S, Dadhania R, Kitzman DW, Arguelles W, Lima J, Youngblood M, Schneiderman N, Daviglus ML, Spevack D, Talavera GA, Raisinghani A, Kaplan R, Rodriguez CJ. Burden of Systolic and Diastolic Left Ventricular Dysfunction Among Hispanics in the United States: Insights From the Echocardiographic Study of Latinos. Circ Heart Fail 2016;9:e002733. [PMID: 27048764 DOI: 10.1161/CIRCHEARTFAILURE.115.002733] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
149 Yang H, Negishi K, Wang Y, Nolan M, Saito M, Marwick TH. Echocardiographic screening for non-ischaemic stage B heart failure in the community. Eur J Heart Fail 2016;18:1331-9. [PMID: 27813300 DOI: 10.1002/ejhf.643] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 8.0] [Reference Citation Analysis]
150 Li J, Yuan Y, Xu S, Zhang N, Xu C, Wan C, Ren J, Zeng X, Tang Q. Arctiin protects against cardiac hypertrophy through inhibiting MAPKs and AKT signaling pathways. Journal of Pharmacological Sciences 2017;135:97-104. [DOI: 10.1016/j.jphs.2017.05.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
151 Reffelmann T, Ittermann T, Dörr M, Völzke H, Reinthaler M, Petersmann A, Felix SB. Low serum magnesium concentrations predict cardiovascular and all-cause mortality. Atherosclerosis 2011;219:280-4. [PMID: 21703623 DOI: 10.1016/j.atherosclerosis.2011.05.038] [Cited by in Crossref: 82] [Cited by in F6Publishing: 75] [Article Influence: 7.5] [Reference Citation Analysis]
152 Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS, Ferdinand KC, Ann Forciea M, Frishman WH, Jaigobin C, Kostis JB, Mancia G, Oparil S, Ortiz E, Reisin E, Rich MW, Schocken DD, Weber MA, Wesley DJ. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Coll Cardiol 2011;57:2037-114. [PMID: 21524875 DOI: 10.1016/j.jacc.2011.01.008] [Cited by in Crossref: 302] [Cited by in F6Publishing: 238] [Article Influence: 27.5] [Reference Citation Analysis]
153 Grodin JL, Tang WH. Treatment strategies for the prevention of heart failure. Curr Heart Fail Rep 2013;10:331-40. [PMID: 24014140 DOI: 10.1007/s11897-013-0154-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
154 Cuspidi C, Negri F, Sala C, Mancia G. Mitral deceleration index is associated with aortic root dilatation and not to biventricular structural changes in essential hypertension. Blood Press 2011;20:190-5. [PMID: 21299440 DOI: 10.3109/08037051.2011.553926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
155 Valensi P, Henry P, Boccara F, Cosson E, Prevost G, Emmerich J, Ernande L, Marcadet D, Mousseaux E, Rouzet F, Sultan A, Ferrières J, Vergès B, Van Belle E. Risk stratification and screening for coronary artery disease in asymptomatic patients with diabetes mellitus: Position paper of the French Society of Cardiology and the French-speaking Society of Diabetology. Diabetes Metab 2021;47:101185. [PMID: 32846201 DOI: 10.1016/j.diabet.2020.08.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
156 Li CY, Zhou Q, Yang LC, Chen YH, Hou JW, Guo K, Wang YP, Li YG. Dual-specificity phosphatase 14 protects the heart from aortic banding-induced cardiac hypertrophy and dysfunction through inactivation of TAK1-P38MAPK/-JNK1/2 signaling pathway. Basic Res Cardiol 2016;111:19. [PMID: 26891723 DOI: 10.1007/s00395-016-0536-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
157 Masaidi M, Cuspidi C, Negri F, Giudici V, Sala C, Zanchetti A, Mancia G. Left and right ventricular structural changes in obese hypertensives. Blood Pressure 2009;18:23-9. [DOI: 10.1080/08037050902850226] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]